CCN 394027, PHILADELPHIA, PA · Medicare cost reports, FY2020–FY2025
Unverified figures. Metrics marked unverified are derived from cost-report coordinates that have not yet been reconciled against audited financial statements. We show you which, rather than hiding it.
Download this hospital as CSV Free. Current year without a key, every year we hold with one.
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total facility beds availableunverified | 172 | 172 | 172 | 169 | 169 | 169 |
| Total bed days availableunverified | 62,952 | 62,780 | 62,780 | 61,685 | 61,685 | 61,685 |
| Total facility dischargesunverified | 4,077 | 4,017 | 3,835 | 3,695 | 3,398 | 3,476 |
| Total facility inpatient daysunverified | 53,111 | 52,730 | 54,611 | 59,569 | 49,697 | 52,060 |
| Total patient revenue (gross charges)unverified | $116,630,270 | $115,318,476 | $127,549,558 | $129,726,984 | $108,377,111 | $117,909,359 |
| Contractual allowances and discountsunverified | $100,482,859 | $96,374,020 | $82,474,569 | $83,139,274 | $66,544,710 | $73,253,000 |
| Net patient revenueunverified | $16,147,411 | $18,944,456 | $45,074,989 | $46,587,710 | $41,832,401 | $44,656,359 |
| Total operating expensesunverified | $15,715,680 | $20,647,474 | $45,299,944 | $47,763,408 | $49,520,517 | $49,569,169 |
| Net income from service to patientsunverified | $431,731 | $-1,703,018 | $-224,955 | $-1,175,698 | $-7,688,116 | $-4,912,810 |
| Net incomeunverified | $1,639,039 | $-990,034 | $1,011,516 | $-468,713 | $-6,860,841 | $-4,438,357 |
| Cost of uncompensated careunverified | $5,723 | — | $18,565 | — | — | — |
| Operating marginunverified | 2.7% | -9.0% | -0.5% | -2.5% | -18.4% | -11.0% |
| Overall cost-to-charge ratiounverified | 13.5% | 17.9% | 35.5% | 36.8% | 45.7% | 42.0% |
| Occupancy rateunverified | 84.4% | 84.0% | 87.0% | 96.6% | 80.6% | 84.4% |
| Average length of stayunverified | 13.0 | 13.1 | 14.2 | 16.1 | 14.6 | 15.0 |
| Uncompensated care as % of operating expenseunverified | 0.0% | — | 0.0% | — | — | — |